Progabide
![](/Images/godic/202502/04/Progabide_structure.svg0331.png")
![Progabide synthesis: C Berthier, J. P. Allaigre, and J. Debois, French Demande, FR 2553763 (1985).](/Images/godic/202502/04/Progabide_synthesis0331.png")
Progabide (INN) (trade name Gabrene, Sanofi-Aventis) is an analogue and prodrug of γ-aminobutyric acid (GABA) used in the treatment of epilepsy. Via conversion into GABA, progabide behaves as an agonist of the GABAA, GABAB, and GABAA-ρ receptors.